...
机译:通过抑制NF-Kappa B途径和ROS生产,HBV抑制LPS诱导的NLRP3炎症组活化和IL-1β生产
Shandong Univ Sch Pharmaceut Sci Inst Immunopharmacol &
Immunotherapy 44 Wenhua West Rd Jinan;
Shandong Univ Sch Pharmaceut Sci Inst Immunopharmacol &
Immunotherapy 44 Wenhua West Rd Jinan;
Shandong Univ Sch Pharmaceut Sci Dept Med Chem Key Lab Chem Biol Nat Prod MOE Jinan 250012;
Shandong Univ Sch Pharmaceut Sci Inst Immunopharmacol &
Immunotherapy 44 Wenhua West Rd Jinan;
Shandong Univ Sch Med Inst Diagnost Jinan 250012 Shandong Peoples R China;
Shandong Prov Hosp Div Liver Dis Jinan 250001 Shandong Peoples R China;
Shandong Prov Hosp Dept Pediat Surg Jinan 250001 Shandong Peoples R China;
Shandong Univ Sch Pharmaceut Sci Inst Immunopharmacol &
Immunotherapy 44 Wenhua West Rd Jinan;
Shandong Univ Sch Pharmaceut Sci Inst Immunopharmacol &
Immunotherapy 44 Wenhua West Rd Jinan;
Univ Sci &
Technol China Sch Life Sci Inst Immunol Hefei 230027 Anhui Peoples R China;
Hepatitis B virus; Hepatitis B e antigens; NLRP3 inflammasome; IL-1 beta; Inflammasomes; Interleukin-1 beta; Reactive oxygen species;
机译:通过抑制NF-Kappa B途径和ROS生产,HBV抑制LPS诱导的NLRP3炎症组活化和IL-1β生产
机译:MD-2通过在肺泡巨噬细胞系中调节LPS诱导的NLRP3炎症体活化和IL-1β分泌物,在肺泡巨噬细胞系中依赖于MyD88 / NF-Kappa B依赖性途径
机译:SINIGROM通过抑制NF-Kappa B / MAPK途径或NLRP3炎症在巨噬细胞中的NLRP3发炎物激活来抑制炎症介质的产生
机译:新型蛋白酶体抑制剂CUCUBRITACIN D对RAW264细胞LPS诱导的IL-1产生的增强效应
机译:循环拉伸力诱导牙周膜细胞分泌外来体,通过抑制巨噬细胞中的NF-κB信号通路抑制IL-1β的产生
机译:SIRT1通过抑制滋养细胞中的NLRP3炎性体激活和ROS产生来减轻LPS诱导的IL-1β产生。
机译:幽门螺杆菌通过ROS信号通路的NLRP3炎炎症激活,幽门螺杆菌在人单核细胞系中诱导IL-1β和IL-18生产